Joerg Beyer

Physician-in-CHief

Inselspital Universitätsspital Bern

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Joerg Beyer is the Physician-in-Chief at Inselspital, Switzerland. His research primarily focuses on oncological outcomes in germ cell cancers, renal cell carcinoma, and advanced prostate cancer. Recent articles highlight his contributions to understanding survival probabilities, treatment methodologies, and prognostic markers in these areas of study.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (5)

robert huddart

Institute of Cancer Research

UNITED KINGDOM

View details

Daniel Engeler

Head of Department

Kantonsspital St. Gallen

SWITZERLAND

View details

Bohuslav Melichar

Professor

University Hospital Olomouc

CZECH REPUBLIC

View details

Arnoud Templeton

University of Basel

SWITZERLAND

View details

Prof. Dr. Niklaus Schaefer

Chief Physician

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joerg Beyer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.

Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.

Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database

Excellent survival in relapsed stage I testicular cancer.

Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma.

No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas.

Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.

Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report.

Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence

Collaborators (5)

robert huddart

Daniel Engeler

Bohuslav Melichar

Arnoud Templeton

Prof. Dr. Niklaus Schaefer

Make your next move.